The estimated Net Worth of Denise M Faltischek is at least $3.14 Milione dollars as of 31 July 2024. Ms Faltischek owns over 93,926 units of Tilray Brands Inc stock worth over $1,003,866 and over the last 15 years she sold TLRY stock worth over $950,508. In addition, she makes $1,189,476 as Head of International & Chief Strategy Officer at Tilray Brands Inc.
Ms has made over 14 trades of the Tilray Brands Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently she exercised 93,926 units of TLRY stock worth $190,670 on 31 July 2024.
The largest trade she's ever made was exercising 389,164 units of Tilray Brands Inc stock on 1 June 2024 worth over $700,495. On average, Ms trades about 27,325 units every 117 days since 2010. As of 31 July 2024 she still owns at least 583,643 units of Tilray Brands Inc stock.
You can see the complete history of Ms Faltischek stock trades at the bottom of the page.
Denise Menikheim Faltischek is the Head of International & Chief Strategy Officer at Tilray Brands Inc.
As the Head of International & Chief Strategy Officer of Tilray Brands Inc, the total compensation of Ms Faltischek at Tilray Brands Inc is $1,189,476. There are 4 executives at Tilray Brands Inc getting paid more, with Irwin David Simon having the highest compensation of $13,683,999.
Ms Faltischek is 48, she's been the Head of International & Chief Strategy Officer of Tilray Brands Inc since . There are 8 older and 4 younger executives at Tilray Brands Inc. The oldest executive at Tilray Brands Inc is Christine St.Clare, 69, who is the Independent Director.
Denise's mailing address filed with the SEC is C/O TILRAY BRANDS, INC., 265 TALBOT STREET WEST, LEAMINGTON, A6, N8H 4H3.
Over the last 6 years, insiders at Tilray Brands Inc have traded over $92,844,538 worth of Tilray Brands Inc stock and bought 140,416 units worth $933,182 . The most active insiders traders include Irwin D Simon, Brendan Kennedy e Mitchell Gendel. On average, Tilray Brands Inc executives and independent directors trade stock every 13 days with the average trade being worth of $215,593. The most recent stock trade was executed by Irwin D Simon on 31 July 2024, trading 706,214 units of TLRY stock currently worth $1,433,614.
tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.
Tilray Brands Inc executives and other stock owners filed with the SEC include: